Neuroprotective effects of urate are mediated by augmenting astrocytic glutathione synthesis and release

Neurobiology of Disease
Rachit BakshiMichael A Schwarzschild

Abstract

Urate has emerged as a promising target for neuroprotection based on epidemiological observations, preclinical models, and early clinical trial results in multiple neurologic diseases, including Parkinson's disease (PD). This study investigates the astrocytic mechanism of urate's neuroprotective effect. Targeted biochemical screens of conditioned medium from urate- versus vehicle-treated astrocytes identified markedly elevated glutathione (GSH) concentrations as a candidate mediator of urate's astrocyte-dependent neuroprotective effects. Urate treatment also induced the nuclear translocation of the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) protein and transcriptional activation of its key target genes in primary astrocytic cultures. Urate's neuroprotective effect was attenuated when GSH was depleted in the conditioned media either by targeting its synthesis or release by astrocytes. Overall, these results implicate GSH as the extracellular astrocytic factor mediating the protective effect of urate in a cellular model of PD. These results also show that urate can employ a novel indirect neuroprotective mechanism via induction of the Nrf2 signaling pathway, a master regulator of the response to oxidative stress, in astro...Continue Reading

References

Sep 29, 1998·Archives of Biochemistry and Biophysics·D MoelleringV M Darley-Usmar
May 20, 2003·Biological Chemistry·Ralf Dringen, Johannes Hirrlinger
Feb 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Gwen S ScottD Craig Hooper
Sep 27, 2005·Journal of Neuroscience Research·H BehbahaniR F Cowburn
Sep 14, 2006·Annual Review of Pharmacology and Toxicology·Thomas W KenslerShyam Biswal
Nov 23, 2006·Nature Clinical Practice. Neurology·Nicholas J Maragakis, Jeffrey D Rothstein
Sep 25, 2008·Molecular Aspects of Medicine·Christopher C FranklinTerrance J Kavanagh
Dec 17, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Marcelo R VargasJeffrey A Johnson
Feb 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Pei-Chun ChenJeffrey A Johnson
Oct 14, 2009·Archives of Neurology·Alberto AscherioUNKNOWN Parkinson Study Group DATATOP Investigators
Mar 31, 2010·PloS One·Kimberly R DrakeAnne K Kenworthy
Oct 16, 2010·Biomarkers in Medicine·Sara CiprianiMichael A Schwarzschild
Nov 16, 2010·Toxicologic Pathology·Marta Sidoryk-WegrzynowiczMichael Aschner
Jan 24, 2012·The Journal of Pharmacology and Experimental Therapeutics·Robert H ScannevinKenneth J Rhodes
Jun 8, 2012·Journal of Neurochemistry·Sara CiprianiMichael A Schwarzschild
Sep 22, 2012·Biochimica Et Biophysica Acta·Shelly C Lu
Dec 19, 2012·Proceedings of the National Academy of Sciences of the United States of America·Xiqun ChenMichael A Schwarzschild
Jan 9, 2013·Annual Review of Pharmacology and Toxicology·Qiang Ma
Dec 17, 2014·BMC Medical Genetics·Malin von OtterHenrik Zetterberg
Dec 2, 2015·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Satvinder Singh Bakshi

❮ Previous
Next ❯

Citations

Dec 1, 2015·Cellular and Molecular Life Sciences : CMLS·Dan LindholmMart Saarma
Apr 17, 2016·Neurotoxicity Research·Marcos Roberto de OliveiraSimone Morelo Dal Bosco
May 18, 2016·Journal of Neuroinflammation·Lulu JiangJau-Shyong Hong
Oct 19, 2016·Lancet Neurology·Alberto Ascherio, Michael A Schwarzschild
Nov 20, 2016·The European Journal of Neuroscience·Anna R CartaElaine Del-Bel
Jan 27, 2016·Journal of Neurochemistry·Edwin K JacksonPatrick M Kochanek
Sep 1, 2017·Muscle & Nerve·Sabrina PaganoniUNKNOWN Pooled Resource Open-Access ALS Clinical Trials Consortium
Feb 15, 2019·Annals of Neurology·Rachit BakshiMichael A Schwarzschild
Dec 21, 2016·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Sabrina Paganoni, Michael A Schwarzschild
Jan 11, 2017·Molecular and Cellular Biochemistry·Bernardo Assein ArúsLarissa Daniele Bobermin
Jul 15, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Marta San LucianoUNKNOWN Michael J. Fox Foundation LRRK2 Cohort Consortium
Feb 23, 2020·Current Drug Targets·Snežana SpasićZorica Stević
Jun 18, 2017·Journal of Neural Transmission·Tommaso SchirinziAntonio Pisani
Dec 20, 2018·Annals of Clinical and Translational Neurology·Katharine NicholsonSabrina Paganoni
Aug 21, 2019·Translational Neurodegeneration·Shirley Yin-Yu PangShu-Leong Ho
Jan 12, 2021·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Frederic MármolAlbert Martínez-Pinteño
Jun 18, 2017·Experimental Neurology·Grace F CrottyMichael A Schwarzschild
Mar 9, 2021·Journal of Parkinson's Disease·Anastasia BougeaLeonidas Stefanis
Nov 13, 2018·EBioMedicine·Xiqun ChenUNKNOWN Parkinson Study Group (PSG) The Safety of Urate Elevation in Parkinson's Disease (SURE-PD) investigators
Jun 23, 2021·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Yannan ZhangHongzhi Pan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Epidemiology of Aging

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.